AstraZeneca knows a thing or two about the EGFR gene thanks to leading cancer med Tagrisso. The med has broad approvals in ...

Figure 1. The schematic diagram depicts various biological fluids (inner circle), and cellular and molecular biomarkers ...

Me and 20 lung cancer advocacy organizations are working to improve lung cancer detection, risk reduction and care.

Oncologic Drugs Advisory Committee (ODAC) has acknowledged that AstraZeneca's Imfinzi (durvalumab) met the primary endpoint ...

Jason Porter, MD, analyzes critical insights from the 2024 ASCO Annual Meeting presentation on progression-free survival data ...

ORIC Pharmaceuticals shares are trading at a premium due to recent announcements. Check out this article to know why I rate ...

Cash will also be earmarked for its EGFR inhibitor franchise. Last year, French pharma Pierre Fabre offered up to $553 ...

Janssen-Cilag International NV, affiliated to drug major Johnson & Johnson (JNJ), announced Friday that the European Medicines ...

The Lung Cancer Research Foundation (LCRF), in collaboration with 23andMe Holding Co., a leading genetic health and ...

Exemption from basic customs duty could potentially reduce the price by 10-20 percent, making these treatments more ...

Customs duty exemptions on three crucial cancer treatment drugs could potentially reduce the cost by 10-20 per cent, reducing ...

To make cancer treatment affordable in India Nirmala Sithraman has slashed the customs duty on three crucial cancer medicines ...